NT_1170x120_1-11-18

low-dose cannabidiol (CBD) oral thin film (OTF)

CURE Pharmaceutical and Canopy Growth to produce CBD oral thin films

CURE Pharmaceutical and Canopy Growth to produce CBD oral thin films

OXNARD, Calif. – CURE Pharmaceutical announced it is collaborating with Canopy Growth Corp. to develop a new low-dose cannabidiol (CBD) oral thin film (OTF) using CURE’s patented CUREfilm technology for global distribution. This CUREfilm license gives Canopy a dosage form that is ideal for administering cannabinoids. “This collaboration builds on our licensing agreement with Canopy